Pulse Biosciences held its 2023 Annual Meeting of Stockholders, where Director Mitchell E. Levinson did not stand for reelection but continues to serve as Chief Strategy Officer. The stockholders voted to elect six directors and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm.